FindTrial
Sign In

Effects of microvascular decompression versus radiofrequent thermocoagulation of the pterygopalatine ganglion in patients with persistent, drug-resistent, Sluder*s neuralgia: a pilot study

Effects of microvascular decompression versus radiofrequent thermocoagulation of the pterygopalatine ganglion in patients with persistent, drug-resistent, Sluder*s neuralgia: a pilot study - MVD versus RF of the pterygopalatine ganglion for Sluder's neuralgia

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30210
Enrollment
24
Registered
2007-10-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pterygopalatine neuralgia Sluder headache

Interventions

Microvascular decompression of the pterygopalatine ganglion by means of insertion of a piece of temporal muscle between the pterygopalatine ganglion and the maxillary artery and clipping of the arte
to ensure discontinuation of contact between the pterygopalatine ganglion and the maxillary artery.

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Persistent, drug-resistent Sluder's neuralgia Persistent, drug-resistent atypical Sluder's neuralgia

Exclusion criteria

Exclusion criteria: major anatomical variations in the area of surgery disease of the maxillary sinus previous surgery in the area of interest pain attributable to another diagnosis

Design outcomes

Primary

MeasureTime frame
Primary outcome measure will be the severity of pain assessed on a Visual Analogue Scale and the mean duration of pain per week in hours.—

Secondary

MeasureTime frame
Secondary outcome measure will be quality of life, assessed with the SF-36 Health Survey and EuroQol questionnaire.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)